AO ITC Clinical Science Advisory Commission

AO ITC Clinical Science Advisory Commission (CSAC) provides strategic advice for AO ITC in its clinical evidence generation and is an important body for innovation at AO ITC. The members of CSAC include experts from the clinical division of Trauma, CMF, and Spine. As of June 2022, a representative for AO VET is also added to the commission.

The purpose of the CSAC is elaborated by Michael Fehlings, the former chair of the CSAC, and Philip Louie in this interview.


Osama Farouk

Osama Farouk, MD

(Trauma Representative)
Prof of Orthopedic Surgery and Chief of Orthopedic Trauma Unit,
Assiut University Hospitals, Egypt

Prof. Dr. Eppo Wolvius, MD, DDS, PhD

(CMF Representative)
Prof and Chair of Department of Oral and MaxFac Surgery, Erasmus University Medical Centre Rotterdam, Netherlands

Theodore Miclau, MD

(Chair)
Professor and Vice Chairman, Department of Orthopaedic Surgery, University of California, San Francisco

Philip Louie

Philip Louie, MD

(Spine Representative)
Spine Surgeon, Department of Neurosurgery,
Virginia Mason Medical Center, Seattle,
USA Chief Operating Officer and Co-Founder of STREAMD

Matthew Allen

Prof Matthew Allen, MA, VetMB, PhD

(VET Representative)
Prof of Small Animal Surgery at the University of Cambridge, UK

 

Find out more

Clinical Evidence

AO ITC clinical research to global standards (ISO 14155 and ICH GCP), drawing on in-house medical and scientific expertise.

Completed studies

We transform ideas into clinical study protocols. AO clinical studies are divided into 5 phases: idea, planning, execution, analysis, and publication.


Clinical Research Fellowship

Apply now to take part in a clinical research fellowship at the AO's Innovation Translation Center.